These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 9504188

  • 1. Hormonal-induced changes on the lipid composition and DPH fluorescence anisotropy of erythrocyte ghost from pre- and postmenopausal women.
    Marra CA, Mangionil JO, Tavella M, del Alaniz MJ, Ortiz D, Sala C.
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(1):8-17. PubMed ID: 9504188
    [Abstract] [Full Text] [Related]

  • 2. Dietary fat and hormonal effects on erythrocyte membrane fluidity and lipid composition in adult women.
    Berlin E, Bhathena SJ, Judd JT, Nair PP, Jones DY, Taylor PR.
    Metabolism; 1989 Aug; 38(8):790-6. PubMed ID: 2761416
    [Abstract] [Full Text] [Related]

  • 3. Dietary and metabolic differences in pre- versus postmenopausal women taking or not taking hormone replacement therapy.
    Reimer RA, Debert CT, House JL, Poulin MJ.
    Physiol Behav; 2005 Feb 15; 84(2):303-12. PubMed ID: 15708782
    [Abstract] [Full Text] [Related]

  • 4. Lower levels of prepulse inhibition in luteal phase cycling women in comparison with postmenopausal women.
    Bannbers E, Kask K, Wikström J, Sundström Poromaa I.
    Psychoneuroendocrinology; 2010 Apr 15; 35(3):422-9. PubMed ID: 19735984
    [Abstract] [Full Text] [Related]

  • 5. Fatty acid composition of serum phospholipid of premenopausal women and postmenopausal women receiving and not receiving hormone replacement therapy.
    Stark KD, Park EJ, Holub BJ.
    Menopause; 2003 Apr 15; 10(5):448-55. PubMed ID: 14501607
    [Abstract] [Full Text] [Related]

  • 6. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 15; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 7. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P, Daures JP, Thezenas S, Guilleux F, Rouanet P, Grenier J.
    Cancer; 1998 Aug 15; 83(4):698-705. PubMed ID: 9708933
    [Abstract] [Full Text] [Related]

  • 8. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
    Koter M, Broncel M, Chojnowska-Jezierska J, Klikczynska K, Franiak I.
    Eur J Clin Pharmacol; 2002 Nov 15; 58(8):501-6. PubMed ID: 12451426
    [Abstract] [Full Text] [Related]

  • 9. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
    Pujol P, Daures JP, Brouillet JP, Chang S, Rouanet P, Bringer J, Grenier J, Maudelonde T.
    Cancer; 2001 May 15; 91(10):1854-61. PubMed ID: 11346866
    [Abstract] [Full Text] [Related]

  • 10. Beta-estradiol effect on erythrocyte aggregation--a controlled in vitro study.
    Gonçalves I, Saldanha C, Martins e Silva J.
    Clin Hemorheol Microcirc; 2001 May 15; 25(3-4):127-34. PubMed ID: 11847415
    [Abstract] [Full Text] [Related]

  • 11. [Features of breast ultrasound image and its correlation with estradiol and progesterone level in different phases of menstrual cycle in normal women].
    Zhou YZ, Jiang YX, Sun Q, Zhang SQ, Zhang Y, Chen FL, Lin SQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec 15; 23(6):609-13. PubMed ID: 12901108
    [Abstract] [Full Text] [Related]

  • 12. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE, Hughes CL, Burger HG, Robertson DM, Fraser IS.
    Menopause; 2009 Dec 15; 16(1):50-9. PubMed ID: 18978637
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Estradiol, progesterone and plasma lipids during the menstrual cycle.
    Basdevant A, De Lignieres B, Bigorie B, Guy-Grand B.
    Diabete Metab; 1981 Mar 15; 7(1):1-4. PubMed ID: 7238973
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Breast epithelial proliferation in postmenopausal women evaluated through fine-needle-aspiration cytology.
    Conner P, Skoog L, Söderqvist G.
    Climacteric; 2001 Mar 15; 4(1):7-12. PubMed ID: 11379380
    [Abstract] [Full Text] [Related]

  • 17. Effects of pre- and postmenopausal use of exogenous hormones on receptor content in normal human breast tissue: a randomized study.
    Hallberg G, Persson I, Naessén T, Magnusson C.
    Gynecol Endocrinol; 2008 Aug 15; 24(8):475-80. PubMed ID: 18850387
    [Abstract] [Full Text] [Related]

  • 18. Variations in steroid hormone receptor content throughout age and menopausal periods, and menstrual cycle in breast cancer patients.
    Nikolić-Vukosavljević D, Vasiljević N, Branković-Magić M, Polić D.
    Neoplasma; 1996 Aug 15; 43(3):163-9. PubMed ID: 8841503
    [Abstract] [Full Text] [Related]

  • 19. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A.
    Ann Acad Med Stetin; 2003 Aug 15; 49():111-30. PubMed ID: 15552843
    [Abstract] [Full Text] [Related]

  • 20. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 15; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.